EGM
CKPT

Engineers Gate Manager’s Checkpoint Therapeutics CKPT Stock Holding History

Engineers Gate Manager’s Portfolio CKPT Stock Details CKPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-17,879
Closed -$40.9K – 1958
2023
Q4 		$40.9K Buy
+17,879
New +$38.9K ﹤0.01% 1861

Other funds holding CKPT

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
LWAM
Legacy Wealth Asset Management Woodbury, Minnesota $456M AUM 35.19% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Engineers Gate Manager's CKPT Position: Q1 2024 in Review

Engineers Gate Manager sold out of Checkpoint Therapeutics (CKPT) in Q1 2024, closing a stake of 17,879 shares — an estimated $40.9K sold.

Engineers Gate Manager first reported a position in CKPT in Q4 2023 and held it in 1 quarter. The position peaked at $40.9K in Q4 2023. 40 funds tracked by Wall St. Rank hold CKPT as of Q1 2024.

  • Engineers Gate Manager reported no remaining Checkpoint Therapeutics position as of Q1 2024 after selling out during the quarter.
  • Engineers Gate Manager sold 17,879 Checkpoint Therapeutics shares in Q1 2024, an estimated $40.9K.
  • Engineers Gate Manager first reported a position in Checkpoint Therapeutics in Q4 2023 and held it in 1 quarter.
  • Engineers Gate Manager's Checkpoint Therapeutics position peaked at $40.9K in Q4 2023.
  • 40 funds tracked by Wall St. Rank held Checkpoint Therapeutics as of Q1 2024.

Based on Engineers Gate Manager's 13F filing for Q1 2024, filed 15 May 2024.